Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Vitamin D deficiency in outpatients with inflammatory bowel disease: prevalence and association with clinical-biological activity.
- Raúl Vicente Olmedo Martín, I. G. Molero, G. O. Fuster, Víctor Amo Trillo, Miguel Jiménez Pérez
The prevalence of 25-hydroxyvitamin D deficiency in a cohort of outpatients with IBD is determined and its association with clinical and biological activity, quality of life and psychological symptoms is assessed. Expand
[Peristomal pyoderma gangrenosum after rectal adenocarcinoma in the context of colonic and complex perianal Crohn's disease].
Apendagitis epiploica una causa infradiagnosticada de dolor abdominal agudo
- Raúl Vicente Olmedo Martín, F. M. Cordero, María Carmen Ortiz Correro, R. M. González
- 1 June 2011
El abdomen era doloroso de forma espontanea exacerbandose a la palpacion profunda del cuadrante inferior izquierdo con defensa voluntaria pero sin signos de irritacion peritoneal. Expand
Inflammatory Bowel Disease: New Therapeutic Options in the Post Anti-TNFα Era
- Miguel Jiménez Pérez, Raúl Vicente Olmedo Martín, Víctor Amo Trillo, R. Gande
- 31 December 1969
Some of the key aspects of these new drugs, including their mechanism of action, some incipient pharmacokinetic and metabolic data, their efficacy and their safety, will take on an important role in the coming years in the management of patients with moderate-to-severe forms of inflammatory bowel disease. Expand
Medium to long-term efficacy and safety of oral tacrolimus in moderate to severe steroid refractory ulcerative colitis.
Assessment of the medium to long-term efficacy and safety of oral tacrolimus in patients with moderate to severe ulcerative colitis refractory to steroids found it to be an effective drug that induces clinical remission. Expand
Efficacy and safety of vedolizumab as a treatment option for moderate to severe refractory ulcerative colitis in two patients after liver transplant due to primary sclerosing cholangitis.
- Raúl Vicente Olmedo Martín, Víctor Amo Trillo, R. Grande, Miguel Jiménez Pérez
- 1 September 2017
The efficacy and safety of vedolizumab after one year of treatment in two patients who underwent a transplant due to primary sclerosing cholangitis are presented and one case had de novo post-transplant ulcerative colitis refractory to two anti-TNFα drugs (golimumab and infliximab). Expand
[Epiploic appendagitis: an underdiagnosed cause of acute abdominal pain].
Rectus abdominal endometriosis on cesarean scar
6. Lyon CC, Smith AJ, Beck MH, Wong GA, Griffiths CE. Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol. 2000;42:992--1002. 7. Funayama Y, Kumagai E, Takahashi K,… Expand